Patent details

Herbas

VPB

Print

EN | LT

Supplementary protection

LT - Angiotenzino receptorių antagonisto ir NEP inhibitoriaus farmaciniai deriniai

EN - PHARMACEUTICAL COMBINATIONS OF AN ANGIOTENSIN RECEPTOR ANTAGONIST AND A NEP INHIBITOR

SPC
(11)	Number of the document	C 2340828
(68)	Number of the document	2340828
(21)	Application number for Supplementary Protection Certificate	PA 2021 502
(22)	Date of filing the application	2021-01-14
(41)	Date of publication of the application	2021-02-10
	Date of publication of SPC	2024-05-10
(24)	Date of coming into effect of SPC	2026-11-09

Applicant
(71)	Novartis Pharma AG, Lichtstrasse 35, 4056 Basel, CH

Grantee
(73)	Novartis Pharma AG, Lichtstrasse 35, 4056 Basel, CH

Attorney or representative
(74)	Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT

Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
(93)	EU/1/15/1058, 2015-11-19

Calculated date of expiry of the SPC
(94)	2030-11-23

Name of the product protected by the basic patent
(95)	Sakubitrilas/valsartanas, kaip sakubitrilo valsartano natrio druskos kompleksas, t.y. [((S)-N-valeril-N-{[2'-(1H-tetrazol-5-il)-bifenil-4-il]-metil}-valinas)((2R,4S)-5-bifenil-4-il-4-(3-karboksi-propionilamino)-2-metil-pentano rūgšties etilo esteris)Na3 · x H2O, kur x yra 0 - 3

Legal status
	SPC lapsed
	Date of negative decision to issue the SPC	2025-05-15